closing ion channels, study finds
Yale School of Medicine and University of Crete School of Medicine researchers report the first evidence of a molecular mechanism that dynamically alters the strength of higher brain network connections.
This discovery, published in the April 20 issue of the journal Cell, may help the development of drug therapies for the cognitive deficits of normal aging, and for cognitive changes in schizophrenia, bipolar disorder or attention deficit hyperactivity disorder (ADHD).
"Our data reveal how the brain's arousal systems influence the cognitive networks that subserve working memory -- which plays a key role in abstract thinking, planning and organizing, as well as suppressing attention to distracting stimuli," says Amy Arnsten, lead author and professor of neurobiology and psychology at Yale.
The brain's prefrontal cortex (PFC) normally is responsible for so-called executive functions. The ability of the PFC to maintain such memory-based functions declines with normal aging, is weakened in people with ADHD, and is severely disrupted in disorders such as schizophrenia and bipolar disorder.
The current study found that brain cells in PFC contain ion channels called hyperpolarization-activated cyclic nucleotide-gated channels (HCN) that reside on dendritic spines, the tiny protrusions on neurons that are specialized for receiving information. These channels can open when they are exposed to cyclic adenosine monophosphate (cAMP). When open, the information can no longer flow into the cell, and thus the network is effectively disconnected. Arnsten says inhibiting cAMP closes the channels and allows the network to reconnect.
The study also found alpha-2A adrenergic receptors near the channels that inhibit the production of cAMP and allow the information to pass through into the cell, connecting the network. These receptors are stimulated by a natural brain chemical norepinephrine or by medications like guanfacine.
"Guanfacine can strengthen the connectivity of these networks by keeping these channels closed, thus improving working memory and reducing distractibility," she says. "This is the first time we have observed the mechanism of action of a psychotropic medication in such depth, at the level of ion channels."
Arnsten says the excessive opening of HCN channels might underlie many lapses in higher cognitive function. Stress, for example, appears to flood PFC neurons with cAMP, which opens HCN channels, temporarily disconnects networks and impairs higher cognitive abilities.
There is also evidence that this pathway may not be properly regulated with advancing age, resulting in destruction of cAMP. The dysregulation of the pathway may contribute to increased forgetfulness and susceptibility to distraction as individuals grow older.
The research is also relevant to common disorders such as ADHD, which is associated with weaker regulation of attention and behavior. ADHD is highly heritable, and it is believed some patients with ADHD may have genetic changes in molecules that weaken the production of norepinephrine. Treatments for ADHD all enhance stimulation of the norepinephrine receptors.
These new data, notes Arnsten, also have important implications for the researchers' studies of more severe mental illnesses like schizophrenia and bipolar disorder, which can involve mutations of a molecule called Disrupted in Schizophrenia (DISC1) that normally regulates cAMP. Loss of function of DISC1 in patients with schizophrenia or bipolar disorder would increase vulnerability to cortical network disconnection and profound PFC deficits. This may be especially problematic during exposure to even mild stress, which may explain the frequent worsening of symptoms following exposure to stress, says Arnsten. "We find it remarkable to relate a genetic mutation in patients to the regulation by an ion channel of PFC neuronal networks."
Co-authors include Min Wang, Brian Ramos, Yousheng Shu, Arthur Simen, Alvaro Duqye, Avis Brennan, Susheel Vijayraghavan, Anne Dudley, Eric Nou, David McCormick, James Mazer and Constantinos Paspalas, who also has an appointment at the University of Crete School of Medicine in Heraklion, Greece.
The work was supported by research grants from the National Institute on Aging and the National Institute of Mental Health, as well as from Shire Pharmaceuticals Group PLC and an award from the Kavli Institute of Neuroscience at Yale.
Arnsten and Yale have a license agreement with Shire Pharmaceuticals for the development of guanfacine for the treatment of patients with ADHD. Yale has submitted a patent application on the use of HCN blockers for the treatment of PFC cognitive deficits based on the data reported in the Cell paper.
-- By Jacqueline Weaver
T H I S
W E E K ' SS T O R I E S
Center's initiative to promote understanding of Middle East
New policies offer academic relief to Ph.D. students who are new parents
Despite challenges, accessibility improving in Yale buildings
'Growing and Learning Together'
Immunology comes of age at the School of Medicine
The nation needs more 'conversation,' says television anchor
SOM HONORS
State Hispanic organization recognizes the school for . . .
First-year students win an online contest involving the simulation . . .
Yale Rep ends season with East Coast premiere of 'The Unmentionables'
Art exhibit explores the question: 'What Is a Line?'
Smoking status a 'red flag' for alcohol misuse, study finds
Study reveals abnormal patterns of facial recognition . . .
Student-made machines will vie in 'Yale Robot Wars' competition
Display explores historical process of globalization
Panel to discuss the early shapers of globalization
Show sketches the lives of residential college namesakes
Divinity School event to examine issues of 'Faith and Citizenship'
Brain networks strengthened by closing ion channels, study finds
Attention deficits found in teen smokers who were exposed to . . .
A2K2 conference will focus on access to knowledge issues
Films and readings will offer insights into views on aging in India and Japan
Center's inaugural conference will explore ways that social . . .
Event showcases medical students' original research
New system eliminates wait time for bus riders
Campus Notes
Bulletin Home|Visiting on Campus|Calendar of Events|In the News
Bulletin Board|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs|News Releases|
E-Mail Us|Yale Home